Mologic Inc.

Mologic Inc.

UEI
UJXLCMKNFXD4
CAGE
894Z0
Primary NAICS
621999 All Other Miscellaneous Ambulatory Health Care Services
SAM.gov registration
Expired

Company facts

Self-certified in SAM.gov
  • Foreign Owned
  • For Profit Organization
Entity structure
Corporate Entity (Not Tax Exempt)
NAICS codes registered in SAM.gov
SAM.gov registration date
Website
globalaccessdx.com
Founded
2003
Employees
51-250
Estimated annual revenue
$10M-$50M
Industry
  1. Health Care
  2. Pharmaceuticals, Biotechnology & Life Sciences
  3. Pharmaceuticals
SIC code
28 Chemical & Allied Products
Profiles

Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .

Recent federal awards

Mologic Inc.'s 2 most recent federal contract and grant awards, newest first. Amounts are dollars obligated.
Award Agency Obligated Awarded
Rapid acceleration of diagnostics (radx) program tech project #7697: sars-COV-2 AG home test Contract · 75N92021C00010 National Heart Lung and Blood Institute $16,239,965
Custom antibody devlopment Contract · 75N93020P00199 National Institute of Allergy and Infectious Diseases $59,010

About Mologic Inc.

Mologic Inc. is a leading developer and manufacturer of advanced lateral flow immunoassay tests for human healthcare, animal health, environmental and food safety markets. Through prime federal contracts, Mologic Inc. has provided SARS-CoV-2 antigen home tests to the National Institutes of Health to accelerate COVID-19 diagnostics. This $16.2 million firm fixed price contract aims to deliver tests through May 2024 out of Mologic's New Hampshire facility. Mologic Inc. has also provided custom antibody development to the NIH's National Institute of Allergy and Infectious Diseases through a $59,010 purchase order completed in June 2020.

As a subcontractor, Mologic Inc. has undertaken unspecified efforts for the Department of Defense through prime contractor Georgia Tech Applied Research Corporation.

Through a federal grant subaward from the University of Massachusetts Medical School, Mologic Inc. is conducting clinical studies on multiple new point-of-care COVID-19 testing devices to examine sensitivity, specificity, usability, feasibility and safety. This work supports the NIH's goal of facilitating public health through rapid testing technologies.

Quick answers

What is Mologic Inc.'s UEI?

Mologic Inc.'s Unique Entity ID (UEI) in SAM.gov is UJXLCMKNFXD4.

What is Mologic Inc.'s CAGE code?

Mologic Inc.'s CAGE code is 894Z0.

What is Mologic Inc.'s primary NAICS code?

Mologic Inc.'s primary NAICS code is 621999 (All Other Miscellaneous Ambulatory Health Care Services).

Is Mologic Inc. registered in SAM.gov?

Mologic Inc.'s SAM.gov registration expired on July 15, 2025.

What is Mologic Inc.'s most recent federal award?

Mologic Inc.'s most recent federal contract award is Rapid acceleration of diagnostics (radx) program tech project #7697: sars-COV-2 AG home test (75N92021C00010), from National Heart Lung and Blood Institute, on March 31, 2021.

On GovTribe

See Mologic Inc.'s full federal record

  • Federal contract awards
  • Subcontracting relationships
  • Funding analysis by agency, NAICS and set-aside
  • Similar vendors